Ethical Issues Relevant to the Assessment of Suicide Risk in Nonclinical Research Settings
Abstract
Background: Our laboratory recently confronted this issue while conducting research with undergraduate students at the University of Waterloo (UW). Although our main objective was to examine cognitive and genetic features of individuals with schizotypal personality disorder (SPD), the study protocol also entailed the completion of various self-report measures to identify participants deemed at increased risk for suicide. Aims and Methods: This paper seeks to review and discuss the relevant ethical guidelines and legislation that bear upon a psychologist’s obligation to further assess and intervene when research participants reveal that they are at increased risk for suicide. Results and Conclusions: In the current paper we argue that psychologists are ethically impelled to assess and appropriately intervene in cases of suicide risk, even when such risk is revealed within a research context. We also discuss how any such obligation may potentially be modulated by the research participant’s expectations of the role of a psychologist, within such a context. Although the focus of the current paper is on the ethical obligations of psychologists, specifically those practicing within Canada, the relevance of this paper extends to all regulated health professionals conducting research in nonclinical settings.
References
1994). Diagnostic and statistical manual of mental disorders. Washington, DC: Author.
(2002). Ethical principles of psychologists and code of conduct (4th ed.). Washington: Author.
(1996). The factor structure of schizotypal symptoms in a clinical population. Schizophrenia Bulletin, 22, 501–509.
(2002). The suicide patient: Clinical and legal standards of care (2nd ed.). Washington, DC: American Psychological Association.
(2009). Comparison of clinical and research assessments of diagnosis, suicide attempt history and suicidal ideation in major depression. Journal of Affective Disorders, 115(1–2), 183–188.
(1988). Schizotypal personality disorder in an outpatient population: Incidence and clinical characteristics. Journal of Clinical Psychology, 44, 322–325.
(2000). Canadian code of ethics for psychologists (3rd ed.). Ottawa: Author.
(1997). Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. American Journal of Psychiatry, 154, 199–204.
(2003). The three-factor model of schizotypal personality: Invariance across age and gender. Personality and Individual Differences, 35, 1007–1019.
(1998). Deliberate self-harm: Systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition. British Medical Journal, 317, 441–447.
(1999). Standard protocol for assessing and treating suicidal behaviors for patients in treatment. In , The Harvard Medical School guide to suicide assessment and intervention (pp. 146–187). San Francisco, CA: Jossey-Bass.
(2004). Comprendre le suicide [
(Understanding suicide ]. Montreal: Presses de l’Universite de Montreal.2005). Ethical and legal issues in suicide research. International Journal of Law and Psychiatry, 28, 23–41.
(1999). Epidemiology of suicide. In , The Harvard Medical School guide to suicide assessment and intervention (pp. 40–51). San Francisco, CA: Jossey-Bass.
(1998). NIMH policy on data and safety monitoring in extramural investigator-initiated clinical trials. Retrieved from www.nimh.gov/research-funding/grants/nimh-policy-on-data-and-safety-monitoring-in-extramural-investigator-initiated-clinical-trials.shtml.
(2006). Prospective studies of suicidal behavior in major depressive and bipolar disorders: What is the evidence for predictive risk factors? Acta Psychiatrica Scandinavica, 114, 151–158.
(2001). Intervention research with persons at high risk for suicidality: Safety and ethical considerations. Journal of Clinical Psychiatry, 62(Suppl. 25), 17–26.
(1998). Prediction of suicide in psychiatric patients. Archives of General Psychiatry, 60(Suppl. 2), 70–74.
(2007). Factors in the assessment of suicidality in youth. CNS Spectrum, 12, 156–162.
(2005). TriCouncil Policy Statement: Ethical conduct for research involving humans. Ottawa: Author.
(1991). The SPQ: A scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin, 17, 555–564.
(2006). Schizotypal Personality: Neurodevelopmental and psychosocial trajectories. Annual Revue of Clinical Psychology, 2, 291–326.
(1994). Cognitive-perceptual, interpersonal, and disorganized features of schizotypal personality. Schizophrenia Bulletin, 20, 191–201.
(2000). Three-factor model of schizotypal personality: Invariance across culture, gender, religious affiliation, family adversity, and psychopathology. Schizophrenia Bulletin, 26, 603–618.
(1999). Methods of adolescent suicide prevention. Journal of Clinical Psychiatry, 60(Suppl. 2), 70–74.
(2001). Ethical and research dilemmas arising from a questionnaire study of psychological morbidity among general practice managers. British Journal of General Practice, 51(462), 32–35.
(1995). Ethical issues in research on adolescent depression and suicidal behavior. Australian Psychologist, 30, 183–186.
(1996). The Declaration of Helsinki (1964): Recommendations guiding physicians in biomedical research involving human subjects. British Medical Journal, 313, 1448.
(2008). WMA Declaration of Helsinki: Ethical principles for medical research involving human subjects. Retrieved from www.wma.net/en/30publications/10policies/b3/index.html.pdf?print-media-type&footer-right=[page]/[toPage].
(2001). A self-report scale to help make psychiatric diagnoses: The Psychiatric Diagnostic Screening Questionnaire. Archives of General Psychiatry, 58, 787–794.
(
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Register for access
- Claim
-
Restore content access
This functionality works only for purchases made as a guest